Scarica l'app Stockscreener
12.24
4.44%
0.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Precedente Chiudi:
$11.72
Aprire:
$11.67
Volume 24 ore:
3.28M
Relative Volume:
1.21
Capitalizzazione di mercato:
$2.61B
Reddito:
$61.10M
Utile/perdita netta:
$-138.36M
Rapporto P/E:
-9.0667
EPS:
-1.35
Flusso di cassa netto:
$-90.59M
1 W Prestazione:
+8.32%
1M Prestazione:
+3.99%
6M Prestazione:
+67.67%
1 anno Prestazione:
+43.66%
Intervallo 1D:
$11.63
$12.36
Intervallo di 1 settimana:
$11.08
$12.55
Portata 52W:
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Nome
Ocular Therapeutix Inc
Settore
Industria
Telefono
781-357-4000
Indirizzo
15 CROSBY DRIVE, BEDFORD, MA
Confronta OCUL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
12.24 | 2.50B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-15 | Iniziato | Chardan Capital Markets | Buy |
| 2025-04-08 | Iniziato | William Blair | Outperform |
| 2025-03-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-11 | Iniziato | Needham | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-20 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-31 | Ripresa | Piper Sandler | Overweight |
| 2024-02-09 | Iniziato | BofA Securities | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-10 | Ripresa | Berenberg | Buy |
| 2021-08-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-11-13 | Reiterato | Raymond James | Strong Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-05-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Iniziato | Raymond James | Strong Buy |
| 2018-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-26 | Iniziato | H.C. Wainwright | Buy |
| 2017-07-12 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-08-11 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Behavioral Patterns of OCUL and Institutional Flows - news.stocktradersdaily.com
Why Ocular Therapeutix Inc. (0OT) stock remains stableIndex Update & Reliable Intraday Trade Plans - newser.com
Will Ocular Therapeutix Inc. stock see PE expansionWeekly Profit Summary & Weekly Top Performers Watchlists - newser.com
Is Ocular Therapeutix Inc. stock a safe haven assetJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Will Ocular Therapeutix Inc. stock pay special dividendsWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet - sharewise.com
Published on: 2025-11-20 06:23:38 - newser.com
Why analysts recommend Ocular Therapeutix Inc. (0OT) stockInflation Watch & Technical Pattern Alert System - newser.com
Why Ocular Therapeutix Inc. (0OT) stock stays on top picksRate Hike & High Return Stock Watch Alerts - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Is Ocular Therapeutix Inc. stock near bottom after declineJuly 2025 Institutional & Intraday High Probability Alerts - newser.com
Will Ocular Therapeutix Inc. stock see insider buyingSell Signal & Long-Term Safe Investment Ideas - newser.com
Published on: 2025-11-19 13:52:30 - newser.com
Why Ocular Therapeutix Inc. (0OT) stock could be top winner2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Will Ocular Therapeutix Inc. stock deliver consistent dividendsQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
Comparing Ocular Therapeutix Inc. in custom built stock radarsStop Loss & Growth Focused Stock Pick Reports - newser.com
Will Ocular Therapeutix Inc. stock go up soonMarket Trend Summary & Detailed Earnings Play Alerts - newser.com
Ocular Therapeutix (OCUL) Soars 5% Ahead of Health Conferences - MSN
Why Ocular Therapeutix Inc. stock is recommended by analystsQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com
Is Ocular Therapeutix Inc. stock a buy in volatile markets2025 Key Lessons & Fast Gain Stock Tips - newser.com
Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):